Amneal Pharmaceuticals Inc’s recent filing unveils that its Director Patel Gautam unloaded Company’s shares for reported $0.66 million on Apr 01 ’25. In the deal valued at $8.30 per share,80,000 shares were sold. As a result of this transaction, Patel Gautam now holds 1,728,886 shares worth roughly $12.47 million.
Then, Patel Tushar Bhikhubhai sold 5,000,000 shares, generating $41,750,000 in total proceeds. Upon selling the shares at $8.35, the 10% Owner now owns 48,578,209 shares.
Before that, Patel Tushar Bhikhubhai bought 5,000,000 shares. Amneal Pharmaceuticals Inc shares valued at $43,750,000 were divested by the 10% Owner at a price of $8.75 per share.
JP Morgan upgraded its Amneal Pharmaceuticals Inc [AMRX] rating to an Overweight from a a Neutral in a research note published on February 24, 2025; the price target was increased to $12 from $9. A number of analysts have revised their coverage, including JP Morgan’s analysts, who increased its forecast for the stock in early September from “an Underweight” to “a Neutral”. Goldman revised its rating on March 08, 2021. It rated AMRX as “a Buy” which previously was an “a Sell”.
Price Performance Review of AMRX
On Monday, Amneal Pharmaceuticals Inc [NASDAQ:AMRX] saw its stock jump 3.30% to $7.21. Amneal Pharmaceuticals Inc shares have fallen nearly -8.96% since the year began. Nevertheless, the stocks have risen 26.71% over the past one year. While a 52-week high of $9.48 was reached on 03/03/25, a 52-week low of $5.18 was recorded on 04/10/25. SMA at 50 days reached $8.20, while 200 days put it at $8.13.
Levels Of Support And Resistance For AMRX Stock
The 24-hour chart illustrates a support level at 7.08, which if violated will result in even more drops to 6.94. On the upside, there is a resistance level at 7.30. A further resistance level may holdings at 7.38. The Relative Strength Index (RSI) on the 14-day chart is 36.59, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.64, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 73.76%. Stochastics %K at 17.41% indicates the stock is a buying.
How much short interest is there in Amneal Pharmaceuticals Inc?
A steep rise in short interest was recorded in Amneal Pharmaceuticals Inc stocks on 2025-03-31, growing by 1.67 million shares to a total of 4.43 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-28 was 2.76 million shares. There was a rise of 37.61%, which implies that there is a positive sentiment for the stock.
